Abstract
in the absence of a clinical response resulted in a longer LOS. Conversely, a strategy of up front bivalirudin led to shorter LOS driven primarily by decreased delays to VAD exchange in the absence of a clinical response. Conclusion: In this single center observation of hemodynamically stable patients with suspected VAD thrombosis, an initial strategy of bivalirudin was associated with greater clinical response rates and shorter delays to VAD exchange in the absence of response compared to alternative anticoagulation strategies.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
